Legault Pierre
Director
2 companies
Insider Signal Score
61
GoodTrades Analyzed
13
12M Win Rate
46.2%
Avg 3M Return
+13.1%
Avg 12M Return
-5.9%
Legault Pierre is a Director at Syndax Pharmaceuticals Inc with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $2.0M based on current market prices.
Holdings by Company
Transaction History
Showing 9 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13, 2023 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 39,000 | $26.84 | $1,046,781.60 | -28.9% | -23.2% | -15.5% | |
| Aug 5, 2022 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 24,000 | $23.02 | $552,381.60 | -27.3% | -6.5% | -17.2% | |
| Dec 22, 2021 | BCYC Bicycle Therapeutics Plc | Director | Sale+OE | 150,000 | $57.69 | $8,653,889.73 | -100% | -30.6% | -47.5% | |
| Dec 22, 2021 | SNDX Syndax Pharmaceuticals Inc | Director | Sale+OE | 44,000 | $21.56 | $948,456.40 | -57.9% | -17.1% | +16.2% | |
| Apr 8, 2021 | BCYC Bicycle Therapeutics Plc | Director | Sale+OE | 24,838 | $31.71 | $787,587.67 | -66.4% | -2.7% | +45.6% | |
| Apr 5, 2021 | BCYC Bicycle Therapeutics Plc | Director | Sale+OE | 162 | $31.07 | $5,033.34 | -100% | +4.8% | +44.0% | |
| Mar 31, 2021 | BCYC Bicycle Therapeutics Plc | Director | Sale+OE | 10,000 | $30.00 | $300,000.00 | -100% | +0.7% | +46.9% | |
| Mar 17, 2021 | BCYC Bicycle Therapeutics Plc | Director | Sale+OE | 7,784 | $29.00 | $225,736.00 | -100% | +6.5% | +48.1% | |
| Mar 12, 2021 | BCYC Bicycle Therapeutics Plc | Director | Sale+OE | 2,216 | $29.00 | $64,264.00 | -100% | +3.7% | +55.9% |